Feature|Articles|March 13, 2024
- Pharmaceutical Executive: March 2024
- Volume 44
- Issue 3
Pharmaceutical Executive: March 2024 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive March 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 2 years ago
How’s Business?about 2 years ago
Eyeing Efficiency for Allabout 2 years ago
Positioning Medical Information as a Trust Driver for Your Brandabout 2 years ago
Straight and Simple Advice Lives On in the Pharma Industryabout 2 years ago
A Return to the Fundamentals in Biotech Investment?about 2 years ago
The Shifting Landscape of the Life Sciences Job Marketabout 2 years ago
Copay Adjustment Programs: What’s Next for Manufacturers?Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
2
FDA Approves Icotyde as Treatment of Moderate-to-Severe Plaque Psoriasis in Adults and Adolescents
3
What Governance Resets Should Pharma Companies Take in Response to AI?
4
Conflict in Middle East Disrupts Pharma Drug Supplies: Report
5